Eli Lilly’s weight-loss pill didn’t work so well, and the stock is plunging
Lilly’s stock tumbled as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook. www.marketwatch.com…
Lilly’s stock tumbled as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook. www.marketwatch.com…
A new, late-stage clinical study shows disappointing results for Eli Lilly’s weight loss pill Orforglipron. The experimental drug has less…
Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan. www.marketwatch.com #Weightloss #drugs…
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid…
An Instagram post by TV personality Gemma Collins which advertised a weight-loss drug and app has been banned. The star…
Spain’s Ministry of Health is investigating Novo Nordisk A/S, developer of the blockbuster weight-loss drug Wegovy, over a potential breach…
(Reuters) -Denmark’s Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million…
McDonald’s stock was heading for its longest losing streak in 12 years after Redburn Atlantic recommended investors sell due to…
Brown-Forman’s stock is having its worst day ever and heading for a 12-year low after the spirits seller fell short…
Philippa Roxby and Elena Bailey Health reporters Getty Images Women using weight-loss jabs are being advised to stop if they…